CLINICAL ROLE -
Trial Initiated for Long-Lasting Injectable PrEP to Block HIV Transmission
HIV drug trial will evaluate cabotegravir’s performance as a pre-exposure prophylaxis.
Read More
Changing HIV Treatments to Overcome Resistance
HIV resistance may necessitate more costly therapies for third-line treatment.
Progress Continues on Reducing HIV Incidence
Global HIV incidence rates drop in some African countries.
Peer-Referral Strategies Improve HIV Diagnosis Rates
Peer referrals for testing can locate people with undiagnosed HIV better than health care providers.
Certain Household Chemicals Linked to Diabetes
Study suggests link between diabetes and exposure to DDT, PCBs, and perfluoroalkyl.
Evidence Supports Link Between Psoriatic Arthritis and Fibromyalgia
Elevated rates of fibromyalgia found in patients with rheumatic diseases, such as psoriatic arthritis.
Warfarin Use in End-Stage Renal Disease Raises Concerns
Patients with atrial fibrillation and end-stage renal disease may face a greater risk of all-cause bleeding without reducing strokes in Warfarin.
Switching Treatments Reduces Long-term Efficacy of Psoriatic Arthritis Drugs
Few prior studies have evaluated the relative effectiveness of earlier and later lines of TNF therapy in psoriatic arthritis.
Cycling TNF Treatments in Psoriatic Arthritis Reduces Efficacy
Few prior studies have evaluated the relative effectiveness of earlier and later lines of TNFi therapy in psoriatic arthritis.
Which is the Most Effective Therapy Approach for Psoriatic Arthritis?
Study evaluates whether etanercept monotherapy treats psoriatic arthritis as effectively as the combination of etanercept and methotrexate.
Does Smoking Contribute to Joint Damage in Psoriatic Arthritis?
Study evaluates whether smoking cigarettes worsens clinical damage in PsA patients as it does in rheumatoid arthritis and ankylosing spondylitis.
Antiarrhythmic Drugs Reduce Short-Term AFib Recurrence
Antiarrhythmic drugs do not impact long-term rate of recurrent atrial fibrillation.
How to Predict Risk of Erosion in Psoriatic Arthritis Patients
Duration of psoriasis at baseline impacts the odds of developing erosion in psoriatic arthritis.
Tofacitinib Shows Positive Results in Phase 3 Psoriatic Arthritis Trial
Tofacitinib may offer an effective oral option for patients with psoriatic arthritis.
Psoriatric Arthritis More Prevalent in Psoriasis Patients Than Previously Believed
Study finds 15.5% of all psoriasis patients had undiagnosed psoriatic arthritis.
Which is the Best Pancreatic Enzyme Product for Cystic Fibrosis?
Study compares Zenpep with Creon for efficacy and safety in the treatment of adolescents and adults with cystic fibrosis-associated exocrine pancreatic insufficiency.
Enbrel Effective in Juvenile Psoriatic Arthritis
Etanercept shows sustained efficacy treating the symptoms of 3 juvenile idiopathic arthritis categories.
Diabetes Predicts Cardiovascular Disease in Psoriatic Arthritis Patients
Psoriatic arthritis patients are more likely to develop conditions such as hypertension, diabetes, obesity, and dyslipidemia.
Health Care Costs Soar for Chronic Pancreatitis
Annual per patient cost for pancreatic therapies and medications found to create significant financial burden.
Biologics Carry Higher Infection Rates in Psoriatic Arthritis
Higher risk of serious infection found with adalimumab and infliximab compared with nonmethotrexate and nonbiologic therapies.
Long-Term Pneumonia Vaccine Efficacy in Patients with Psoriatic Arthritis
Patients with inflammatory rheumatic diseases may not need more frequent vaccinations.
Which Is More Effective in Patients with Psoriatic Arthritis: Biologic Combination or Monotherapy?
Researchers compare efficacy and side effects of different psoriatic arthritis treatment options.
Psychological Symptoms Impact Rheumatoid Arthritis Disease Activity
Research suggests psychosocial comorbidities and elevated risk of atherosclerosis in RA patients.
What Is the Best Intervention for Improving Psoriatic Arthritis Medication Adherence?
Research compares multidimensional approaches with uni-dimensional interventions.
What Makes Treating Psoriatic Arthritis So Expensive?
Prescription drugs costs for patients with psoriatic arthritis tended to be higher than comparable costs for ankylosing spondylitis.
Combination Approach Needed to Accurately Measure Quality of Life in Patients with Psoriatic Arthritis
Balanced approach needed to better discriminate between high and low disease activity.
Golimumab Reduces Symptom Severity in Patients with Psoriatic Arthritis
Patients who received golimumab and methotrexate reported larger improvements than monotherapy patients.
Symptom Severity Decreases in Patients with Psoriatic Arthritis who Undergo Weight-Loss Surgery
Significant weight loss found to reduce disease burden in psoriatic arthritis patients.
Psoriatic Arthritis Carries Higher Cardiovascular Disease Risk
Combination of risk factors and PsA disease activity found increase dangers of cardiovascular disease.